Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 3
1964 2
1965 2
1966 2
1967 1
1971 3
1982 1
1983 3
1984 5
1985 2
1986 1
1987 3
1988 3
1989 4
2007 1
2008 1
2009 3
2010 1
2011 2
2012 4
2013 2
2014 1
2015 1
2017 1
2019 3
2020 7
2021 10
2022 15
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Teleneurology in the COVID–19 era.
Moro E, Meoni S. Moro E, et al. Among authors: meoni s. In: Priori A, editor. NEUROLOGY OF COVID–19 [Internet]. Milano: Milano University Press; 2021 Feb. Chapter 15. In: Priori A, editor. NEUROLOGY OF COVID–19 [Internet]. Milano: Milano University Press; 2021 Feb. Chapter 15. PMID: 35507707 Free Books & Documents. Review. No abstract available.
COVID-19 and Parkinsonism: A Critical Appraisal.
Cavallieri F, Fioravanti V, Bove F, Del Prete E, Meoni S, Grisanti S, Zedde M, Pascarella R, Moro E, Valzania F. Cavallieri F, et al. Among authors: meoni s. Biomolecules. 2022 Jul 11;12(7):970. doi: 10.3390/biom12070970. Biomolecules. 2022. PMID: 35883526 Free PMC article. Review.
Sex differences in movement disorders.
Meoni S, Macerollo A, Moro E. Meoni S, et al. Nat Rev Neurol. 2020 Feb;16(2):84-96. doi: 10.1038/s41582-019-0294-x. Epub 2020 Jan 3. Nat Rev Neurol. 2020. PMID: 31900464 Review.
Early Parkinson's Disease Phenotypes Tailored by Personality, Behavior, and Motor Symptoms.
Meira B, Lhommée E, Schmitt E, Klinger H, Bichon A, Pélissier P, Anheim M, Tranchant C, Fraix V, Meoni S, Durif F, Houeto JL, Azulay JP, Moro E, Thobois S, Krack P, Castrioto A; Honeymoon study group. Meira B, et al. Among authors: meoni s. J Parkinsons Dis. 2022;12(5):1665-1676. doi: 10.3233/JPD-213070. J Parkinsons Dis. 2022. PMID: 35527563
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
Clinical perspectives of adaptive deep brain stimulation.
Guidetti M, Marceglia S, Loh A, Harmsen IE, Meoni S, Foffani G, Lozano AM, Moro E, Volkmann J, Priori A. Guidetti M, et al. Among authors: meoni s. Brain Stimul. 2021 Sep-Oct;14(5):1238-1247. doi: 10.1016/j.brs.2021.07.063. Epub 2021 Aug 8. Brain Stimul. 2021. PMID: 34371211 Free article. Review.
Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson's disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial.
Laurencin C, Timestit N, Marques A, Duchez DD, Giordana C, Meoni S, Huddlestone M, Danaila T, Anheim M, Klinger H, Vidal T, Fatisson M, Caire C, Nourredine M, Boulinguez P, Dhelens C, Ballanger B, Prange S, Bin S, Thobois S. Laurencin C, et al. Among authors: meoni s. J Neurol. 2023 Oct;270(10):4851-4859. doi: 10.1007/s00415-023-11814-y. Epub 2023 Jun 20. J Neurol. 2023. PMID: 37338615 Free PMC article. Clinical Trial.
87 results